BlackRock Japan’s Sage Therapeutics SAGE Stock Holding History

BlackRock Japan’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$11K	Buy	221 +77	+53%	+$3.63K	﹤0.01%	1210
2016 Q3	$7K	Buy	+144	New	+$5.86K	﹤0.01%	1237
2015 Q3	–	Sell	-1,575	Closed	-$115K	–	1342
2015 Q2	$115K	Sell	1,575 -837	-35%	-$53.8K	﹤0.01%	950
2015 Q1	$121K	Buy	2,412 +1,917	+387%	+$82.4K	﹤0.01%	937
2014 Q4	$18K	Buy	495 +93	+23%	+$3.47K	﹤0.01%	1223
2014 Q3	$13K	Buy	+402	New	+$11.6K	﹤0.01%	1193

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock Japan's SAGE Position: Q4 2016 in Review

BlackRock Japan increased its Sage Therapeutics (SAGE) stake by 53% in Q4 2016, buying an estimated $3.63K and bringing the position to 221 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1210.

BlackRock Japan first reported a position in SAGE in Q3 2014 and has held it in 6 quarters since. The position peaked at $121K in Q1 2015. 166 funds tracked by Wall St. Rank hold SAGE as of Q4 2016.

BlackRock Japan held 221 shares of Sage Therapeutics worth $11K as of Q4 2016.
BlackRock Japan bought 77 Sage Therapeutics shares in Q4 2016, an estimated $3.63K.
Sage Therapeutics made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1210 holding.
BlackRock Japan first reported a position in Sage Therapeutics in Q3 2014 and has held it in 6 quarters since.
BlackRock Japan's Sage Therapeutics position peaked at $121K in Q1 2015.
166 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.